{"DataElement":{"publicId":"3075406","version":"1","preferredName":"Additional Treatment Progression Reason","preferredDefinition":"Identifies the type of recurrence of cancer after a documented disease free interval.","longName":"ADD_TREAT_PROG_RSN","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2196244","version":"1","preferredName":"Additional Treatment Progression","preferredDefinition":"information related to the additional treatment for progression.","longName":"ADD_TX_PROG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206682","version":"1","preferredName":"Additional Therapy","preferredDefinition":"Added; extra. (from American Heritage Dictionary):An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25406:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FFCA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177380","version":"1","preferredName":"Progression","preferredDefinition":"Progression; advancement in extent or severity.","longName":"Progression","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Progression","conceptCode":"C25331","definition":"Progression; advancement in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5267-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE80BE2B-9BBB-0CFD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3075398","version":"1","preferredName":"Cancer Progression Reason","preferredDefinition":"The values that describe the type of recurrence of cancer.","longName":"CA_PROG_RSN","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Maintenance therapy","valueDescription":"Maintenance Therapy","ValueMeaning":{"publicId":"3075399","version":"1","preferredName":"Maintenance Therapy","longName":"3075399","preferredDefinition":"The act of sustaining something in its current form or proper condition; upkeep.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maintenance","conceptCode":"C53297","definition":"The act of sustaining something in its current form or proper condition; upkeep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3C5C-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3C75-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Additional adjuvant therapy","valueDescription":"Additional Adjuvant Therapy","ValueMeaning":{"publicId":"3075400","version":"1","preferredName":"Additional Adjuvant Therapy","longName":"3075400","preferredDefinition":"Added; extra. (from American Heritage Dictionary): serving to aid or contribute; auxiliary. (Merriam-Webster OnLine): An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adjuvant Generic","conceptCode":"C25722","definition":"Serving to aid or contribute; auxiliary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3C83-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3C9C-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"New lesions","valueDescription":"New Lesion","ValueMeaning":{"publicId":"3075401","version":"1","preferredName":"New Lesion","longName":"3075401","preferredDefinition":"New; having no previous example or precedent or parallel.: (LEE-zhun) An area of abnormal tissue change.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3CA6-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3CBF-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Increased tumor marker","valueDescription":"Increase Neoplasm Biomarker","ValueMeaning":{"publicId":"3075402","version":"1","preferredName":"Increase Neoplasm Biomarker","longName":"3075402","preferredDefinition":"Increase; a process of becoming larger or more numerous or more important.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3CCD-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3CE6-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Increased tumor size","valueDescription":"Increase Neoplasm Size","ValueMeaning":{"publicId":"3075403","version":"1","preferredName":"Increase Neoplasm Size","longName":"3075403","preferredDefinition":"Increase; a process of becoming larger or more numerous or more important.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Size; the physical magnitude of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3CF4-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3D0D-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Patient has been disease free after treatment, no recurrence","valueDescription":"Patient has been disease free after treatment, no recurrence","ValueMeaning":{"publicId":"3075404","version":"1","preferredName":"Patient has been disease free after treatment, no recurrence","longName":"3075404","preferredDefinition":"Patient has been disease free after treatment, no recurrence","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3D17-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3D30-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3D3A-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84D9F5AF-3D44-FC50-E040-BB89AD4356DB","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","deletedIndicator":"No"},{"value":"Abnormal lab values","valueDescription":"Abnormal Laboratory Value","ValueMeaning":{"publicId":"3126122","version":"1","preferredName":"Abnormal Laboratory Value","longName":"3126122","preferredDefinition":"Deviating from the norm.: Laboratory; a workplace for the conduct of scientific research.: The information contained in a data field.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Data Value","conceptCode":"C49100","definition":"The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-80C6-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D01180C-80DF-B8B4-E040-BB89AD432507","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"ONEDATA","dateModified":"2010-08-04","deletedIndicator":"No"},{"value":"Relapse; recurrence, NOS","valueDescription":"Relapse Recurrence Not Otherwise Specified","ValueMeaning":{"publicId":"3126123","version":"1","preferredName":"Relapse Recurrence Not Otherwise Specified","longName":"3126123","preferredDefinition":"The return of signs and symptoms of cancer after a period of improvement.: To occur again.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relapse","conceptCode":"C0699753","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-80ED-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D01180C-8106-B8B4-E040-BB89AD432507","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"ONEDATA","dateModified":"2010-08-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3075397","version":"1","preferredName":"Cancer Progression Reason","preferredDefinition":"The worsening of a cancer over time.:An explanation of the cause of some phenomenon or action.","longName":"C19987:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Progression","conceptCode":"C19987","definition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3C35-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"ONEDATA","dateModified":"2010-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F5AF-3C46-FC50-E040-BB89AD4356DB","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3021954","version":"1","longName":"Caris Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3060676","version":"1","longName":"Caris Registry","context":"NCIP"}]},{"publicId":"3595692","version":"1","longName":"Miraca Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3595693","version":"1","longName":"Miraca Registry","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Type of Progression/Recurrence","type":"Preferred Question Text","description":"Type of Progression/Recurrence","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84D9F8CB-1CF3-2AA4-E040-BB89AD431CB3","latestVersionIndicator":"Yes","beginDate":"2010-04-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-22","modifiedBy":"MAESKEB","dateModified":"2012-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}